BION.SW

BB Biotech AG [BION.SW] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

BION.SW Stock Summary

Top 10 Correlated ETFs

BION.SW

Top 10 Correlated Stocks

BION.SW

In the News

BION.SW Financial details

Company Rating
-
Market Cap
2.34B
Income
-206.61M
Revenue
-186.3M
Book val./share
-
Cash/share
-
Dividend
2.85
Dividend %
6.42%
Employees
10
Optionable
No
Shortable
Yes
Earnings
19 Apr 2024
P/E
-6.88
Forward P/E
-
PEG
6.04
P/S
-7.36
P/B
1.09
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-5.76
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
NAN%
Revenue Q/Q
-373.12%
EPS Q/Q
-
-
-
-
-
SMA20
-4.17%
SMA50
4.55%
SMA100
27.78%
Inst Own
-
Inst Trans
-
ROA
-14%
ROE
-15%
ROC
-0.14%
Gross Margin
100%
Oper. Margin
106%
Profit Margin
106%
Payout
-45%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
35.35-50.7
52W High
-7.8%
52W Low
+31.71%
RSI
50
Rel Volume
1.39
Avg Volume
66.07K
Volume
91.62K
Perf Week
-0.32%
Perf Month
0.88%
Perf Quarter
43.84%
Perf Half Y
39.7%
-
-
-
-
Beta
0.835
-
-
Volatility
0.42%, 1.13%
Prev Close
-0.32%
Price
46.1
Change
2.79%

BION.SW Financial Performance

BION.SW Dividend History

BION.SW Frequently Asked Questions

What is BB Biotech AG stock symbol ?

BB Biotech AG is a CH stock and trading under the symbol BION.SW

What is BB Biotech AG stock quote today ?

BB Biotech AG stock price is $46.1 today.

Is BB Biotech AG stock public?

Yes, BB Biotech AG is a publicly traded company.

Something similar

Top by Market Cap
APC.DE
FB2A.DE
V
ABEC.DE
AMZ.DE
Top Correlated ETFs
185680.KS
WBIO.L
Top Correlated Stocks
BBZA.DE
0K05.L
603305.SS
605116.SS
RBD.L
Similar Market Cap
1881.HK
000779.SZ
603980.SS
ELCO.TA
DVL.WA

Company Profile

Healthcare Biotechnology

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.